Zerbinati, Nicola

Effect of a quality-controlled fermented nutraceutical on skin aging markers: An antioxidant-control, double-blind study

BERTUCCELLI, G., ZERBINATI, N., MARCELLINO, M., NANDA KUMAR, N. S., HE, F., TSEPAKOLENKO, V., CERVI, J., LORENZETTI, A., & MAROTTA, F. (2016) · Experimental and Therapeutic Medicine

Skin Protection and AgingPapaya Research and Applications

Cited by 36

A Practical Approach for the In Vitro Safety and Efficacy Assessment of an Anti-Ageing Cosmetic Cream Enriched with Functional Compounds

Zerbinati, N., Sommatis, S., Maccario, C., Di Francesco, S., Capillo, M. C., Grimaldi, G., Rauso, R., Herrera, M., Bencini, P. L., & Mocchi, R. (2021) · Molecules

Skin Protection and AgingContact Dermatitis and Allergies

Cited by 16

Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces

Di Pierro, F., Sagheddu, V., Galletti, S., Casaroli, A., Labrini, E., Soldi, S., Cazzaniga, M., Bertuccioli, A., Matera, M., Cavecchia, I., et al. (2026) · Probiotics and Antimicrobial Proteins

Probiotics and Fermented FoodsEscherichia coli research studies

Cited by 5

JAK Inhibitors in Atopic Dermatitis: Does Weight Matter? A Real-World, Nationwide Retrospective Study: IL-AD (Italian Landscape Atopic Dermatitis)

Rossi, M., Bighetti, S., Narcisi, A., Costanzo, A., Bianco, M., Malagoli, P., Messina, F., Gaiani, F., Ferrucci, S. M., Marzano, A. V., et al. (2025) · Dermatology and Therapy

Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis

Cited by 5

E. coli 5C: a probiotic effective for preventing post-colonoscopy gastrointestinal discomfort?

DI PIERRO, F., CAZZANIGA, M., BERTUCCIOLI, A., PALAZZI, C. M., CAVECCHIA, I., MATERA, M., & ZERBINATI, N. (2026) · Minerva Gastroenterology

Probiotics and Fermented FoodsGastrointestinal motility and disorders

Cited by 3

Predictors of Response to Topical Ruxolitinib in Non‐segmental Vitiligo: A Narrative Review

Bettolini, L., Maione, V., Carugno, A., Fratton, Z., Errichetti, E., Crivellari, M., Cartocci, A., Maronese, C. A., Venturini, M., Zerbinati, N., et al. (2026) · Australasian Journal of Dermatology

melanin and skin pigmentationDermatologic Treatments and Research

Cited by 3

Tildrakizumab in Managing Psoriasis with Involvement of Difficult-to-Treat Areas: A Multicenter Real-Life Retrospective Study

Cascio Ingurgio, R., Alfano, A., Matteodo, E., Ibba, L., Gargiulo, L., Paolino, G., Mercuri, S. R., Carugno, A., Zerbinati, N., Bighetti, S., et al. (2026) · Journal of Clinical Medicine

Psoriasis: Treatment and PathogenesisDermatology and Skin Diseases

Cited by 3

Draft genome sequence of non-pathogenic Escherichia coli 5C LMG S-33222, isolated from healthy donor feces

Di Pierro, F., Zerbinati, N., Guasti, L., Cazzaniga, M., Bertuccioli, A., Palazzi, C. M., Labrini, E., Sagheddu, V., & Soldi, S. (2024) · Microbiology Resource Announcements

Escherichia coli research studiesProbiotics and Fermented Foods

Cited by 2